Physician profile
Vinay Chandrasekhara
NPI 1265641187
$63,502.00
in general payments reported to CMS, 2019-2025
11 companies · $35K in 2025
The $35K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,929 · 2020: $6,175 · 2021: $235 · 2022: $16K · 2023: $2,011 · 2024: $2,899 · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Consulting Fee: $9,000 · Travel and Lodging: $4,750 · Food and Beverage: $3,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,500.00 |
| Consulting Fee | $9,000.00 |
| Travel and Lodging | $4,750.10 |
| Food and Beverage | $3,273.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $53,585.47 | 2019-2025 | General - Therapies, Exalt Model D, Wallflex Duodenal |
| Covidien LP | $5,900.00 | 2020 | |
| Cook Medical LLC | $1,887.97 | 2019-2024 | Echotip Insight |
| Medtronic, INC. | $1,000.00 | 2022 | |
| Olympus America INC. | $325.08 | 2019-2025 | Visiglide |
| Olympus Corporation of The Americas | $312.50 | 2020-2025 | Single Use Repositionable Clip |
| Fujifilm Healthcare Americas Corporation | $209.51 | 2023 | Fujifilm |
| Ambu INC. | $168.02 | 2020 | |
| Apollo Endosurgery US INC | $57.35 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $56.10 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Chandrasekhara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.